Market news

Detailed price information for Maze Therapeutics Inc (MAZE-Q) from The Globe and Mail including charting and trades.

Moby summary of Xtant Medical Holdings, Inc.'s Q2 2026 earnings call

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the second quarter ended June 30, 2026.

Despite a challenging quarter with declining revenue and margins, Xtant is positioning for growth through the Dillon integration and new product launches targeting a $7.5 billion market.

Motley Fool Press Release.

--Xtant Medical Holdings, Inc., a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 46 th Annual Growth Conference, which is being held August 11-13, 2026, in Boston.